Bill Plovanic | CFO |
Kelly Huang | CEO |
Kyle Rose | Canaccord Genuity |
Rick Wise | Stifel Nicolaus |
Suraj Kalia | Northland Securities |
Good day, ladies and gentlemen, and welcome to the Obalon Therapeutics' Fourth Quarter and Full-year 2018 Financial Results Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] As a reminder, today's call will be recorded. I would now like to turn the call over to Bill Plovanic, Chief Financial Officer for Obalon.